Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer

Gavin M Young1, Vijayababu M Radhakrishnan2, Sara M Centuori3

  • 1Undergraduate Biomedical Research Program, University of Arizona Cancer Center, 1515 N. Campbell Ave, Tucson, 85724, Arizona, USA. gyoung@email.arizona.edu.

BMC Cancer
|November 1, 2015
PubMed
Abstract

Insights

The 14-3-3 eta gene acts as a tumor suppressor, with its expression decreased in colon tumors due to DNA hypermethylation. This finding links 14-3-3 protein levels to colon cancer development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The 14-3-3 protein family comprises seven human isoforms crucial for cellular processes.
  • Dysregulation of 14-3-3 levels is implicated in cancer development.

Purpose of the Study:

  • To investigate 14-3-3 isoform expression in colorectal adenocarcinomas.
  • To explore the epigenetic mechanisms underlying altered 14-3-3 expression in colon tumors.
  • To determine the tumor suppressor role of 14-3-3 eta.

Main Methods:

  • Quantitative reverse transcription PCR (qRT-PCR) for gene expression analysis.
  • Bisulfite sequencing for promoter methylation analysis.
  • Focus formation assays to assess transforming capability.

Main Results:

  • Down-regulation of 14-3-3 sigma, eta, and zeta isoforms in colon adenocarcinomas compared to normal tissue.
  • Identification of novel CpG methylation sites in the 14-3-3 eta promoter, suggesting epigenetic silencing.
  • 14-3-3 eta demonstrated the ability to suppress Ras-induced NIH3T3 cell transformation.

Conclusions:

  • The 14-3-3 eta gene is identified as a tumor suppressor in the context of colon cancer.
  • DNA hypermethylation-induced silencing of 14-3-3 eta contributes to colon tumorigenesis.
  • Altered 14-3-3 expression is linked to colon cancer development.